Literature DB >> 7009736

Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells.

L B Schwartz, R A Lewis, D Seldin, K F Austen.   

Abstract

beta-Hexosaminidase, beta-glucuronidase, arylsulfatase, and tryptase were each released along with histamine from dispersed purified human lung mast cells of 40 to 80% purity by rabbit IgG anti-human IgE. The net per cent release ratio of each enzyme to histamine was determined over all doses of antibody employed to activate the mast cells and over all time points after activation, and indicated the per cent of each enzyme stored in secretory granules along with histamine. By multiplying the net per cent release ratio of each enzyme to histamine by total enzyme content in a preparation of 10(6) mast cells, values for secretory granule content per 10(6) mast cells were found to be 3.8 U for beta-hexosaminidase, 0.03 U for beta-glucuronidase, 0.03 U for arylsulfatase, and 0.9 U for tryptase. Subtype analysis of beta-hexosaminidase by diethylaminoethyl- (DEAE) cellulose chromatography revealed that the B isomer predominates in human mast cell secretory granules, whereas the A isomer predominates in secretory granules of the rat mast cell. Tryptase, the predominant neutral protease of the human mast cell secretory granule, has a m.w. of 130,000 by gel filtration chromatography, whereas the major neutral protease of the rat mast cell is chymotryptic and of 25,000 m.w. The presence of acid hydrolases, a tryptase, and histamine in human mast cell secretory granules suggests that the activated mast cell plays a direct role in the production of acute and subacute inflammation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Inhibitory effect of tannins from galls of Carpinus tschonoskii on the degranulation of RBL-2H3 Cells.

Authors:  Parida Yamada; Takako Ono; Hideyuki Shigemori; Junkyu Han; Hiroko Isoda
Journal:  Cytotechnology       Date:  2012-06-06       Impact factor: 2.058

2.  Cloning and characterization of a second complementary DNA for human tryptase.

Authors:  J S Miller; G Moxley; L B Schwartz
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 3.  Biological implications of preformed mast cell mediators.

Authors:  Anders Lundequist; Gunnar Pejler
Journal:  Cell Mol Life Sci       Date:  2010-11-11       Impact factor: 9.261

4.  Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors.

Authors:  Neerad C Mishra; Jules Rir-sima-ah; R Thomas Boyd; Shashi P Singh; Sravanthi Gundavarapu; Raymond J Langley; Seddigheh Razani-Boroujerdi; Mohan L Sopori
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 5.  Tryptase and chymase, markers of distinct types of human mast cells.

Authors:  S S Craig; L B Schwartz
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

6.  Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism.

Authors:  Vittorio Fineschi; Irene Riezzo; Santina Cantatore; Cristoforo Pomara; Emanuela Turillazzi; Margherita Neri
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

7.  Mast cell tryptases: examination of unusual characteristics by multiple sequence alignment and molecular modeling.

Authors:  D A Johnson; G J Barton
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

8.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

Authors:  B L Gruber; M J Marchese; K Suzuki; L B Schwartz; Y Okada; H Nagase; N S Ramamurthy
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Polyphenols differentially inhibit degranulation of distinct subsets of vesicles in mast cells by specific interaction with granule-type-dependent SNARE complexes.

Authors:  Yoosoo Yang; Jung-Mi Oh; Paul Heo; Jae Yoon Shin; Byoungjae Kong; Jonghyeok Shin; Ji-Chun Lee; Jeong Su Oh; Kye Won Park; Choong Hwan Lee; Yeon-Kyun Shin; Dae-Hyuk Kweon
Journal:  Biochem J       Date:  2013-03-15       Impact factor: 3.857

10.  Acteoside inhibits type Ι allergy through the down-regulation of Ca/NFAT and JNK MAPK signaling pathways in basophilic cells.

Authors:  Hideko Motojima; Myra O Villareal; Rieko Iijima; Junkyu Han; Hiroko Isoda
Journal:  J Nat Med       Date:  2013-03-15       Impact factor: 2.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.